Glycemic outcome associated with insulin pump and glucose sensor use in children and adolescents with type 1 diabetes
This article presents the results of the study that aimed to determine whether insulin pumps and continuous glucose monitors (CGM) are efficacious in maintaining normal blood glucose and glycated hemoglobin concentration (HbA1c) in diabetic patients. The sample size was 25,000 pediatric patients with type 1 diabetes mellitus (T1DM) (Cardona-Hernandez et al., 2021). The entire cohort was divided into four distinct groups that represented participants with one of the devices, pump or CGM, both tools, or no wearable technology (Cardona-Hernandez et al., 2021). Overall, the comparison of different groups showed that individuals who had both insulin pumps and CGMs had better HbA1c concentration than those who wore one or no device.
Text‐message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes
This paper discusses the outcomes of interventional research with T1DM adolescent patients. The methodology required messaging diabetic teenage patients about the need to check and report their blood glucose concentrations. This study demonstrated that the participants who continuously sent their glycemic levels for 1.5 years had HbA1c below 7.5%, which is high but closer to normal (McGill et al., 2019). In contrast, low-responders had increased concentrations of glycated hemoglobin, which was harmful to their organs and tissue in the long term (McGill et al., 2019). Overall, this manuscript showed the importance and effectiveness of monitoring blood glucose in adolescents with T1DM.
Technology in the management of type 1 diabetes mellitus – Current status and future prospects
This review article concentrates on modern technological devices that were invented to help diabetic patients maintain normal glycemic levels and monitor their blood sugar concentration. The authors talk about the advantages and drawbacks of various insulin delivery apparatuses and glucose measuring tools (Tauschmann & Hovorka, 2018). Moreover, the manuscript discusses different data-management apps that help clinicians remotely monitor T1DM patients’ blood glucose levels (Tauschmann & Hovorka, 2018). Finally, the paper provides information about automated insulin-delivery tools that are still being tested in randomized clinical trials.
References
Cardona-Hernandez, R., Schwandt, A., Alkandari, H., Bratke, H., Chobot, A., Coles, N., Corathers, S., Goksen, D., Goss, P., Imane, Z., Nagl, K., O’Riordan, S.M.P., & Jefferies, C. (2021). Glycemic outcome associated with insulin pump and glucose sensor use in children and adolescents with type 1 diabetes. Data from the international pediatric registry SWEET.Diabetes Care, 44(5), 1176-1184. Web.
McGill, D. E., Volkening, L. K., Butler, D. A., Wasserman, R. M., Anderson, B. J., & Laffel, L. M. (2019). Text‐message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes. Diabetic Medicine, 36(5), 600-605. Web.
Tauschmann, M., & Hovorka, R. (2018). Technology in the management of type 1 diabetes mellitus – Current status and future prospects.Nature Reviews Endocrinology, 14(8), 464-475. Web.